These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1420187)

  • 21. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
    J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.
    Inouye H; Fraser PE; Kirschner DA
    Biophys J; 1993 Feb; 64(2):502-19. PubMed ID: 8457674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.
    Fraser PE; Nguyen JT; McLachlan DR; Abraham CR; Kirschner DA
    J Neurochem; 1993 Jul; 61(1):298-305. PubMed ID: 8515277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.
    Prelli F; Castaño EM; van Duinen SG; Bots GT; Luyendijk W; Frangione B
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1150-5. PubMed ID: 3281669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD; Condron MM; Teplow DB
    J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
    Zagorski MG; Barrow CJ
    Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.
    Tomiyama T; Asano S; Furiya Y; Shirasawa T; Endo N; Mori H
    J Biol Chem; 1994 Apr; 269(14):10205-8. PubMed ID: 8144598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type).
    Bakker E; van Broeckhoven C; Haan J; Voorhoeve E; van Hul W; Levy E; Lieberburg I; Carman MD; van Ommen GJ; Frangione B
    Am J Hum Genet; 1991 Sep; 49(3):518-21. PubMed ID: 1679289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitinated neurites are associated with preamyloid and cerebral amyloid beta deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type.
    Tagliavini F; Giaccone G; Bugiani O; Frangione B
    Acta Neuropathol; 1993; 85(3):267-71. PubMed ID: 8384771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.
    Castaño EM; Prelli F; Soto C; Beavis R; Matsubara E; Shoji M; Frangione B
    J Biol Chem; 1996 Dec; 271(50):32185-91. PubMed ID: 8943274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis--Dutch type.
    Timmers WF; Tagliavini F; Haan J; Frangione B
    Neurosci Lett; 1990 Oct; 118(2):223-6. PubMed ID: 2274275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides.
    Maury CP; Nurmiaho-Lassila EL; Rossi H
    Lab Invest; 1994 Apr; 70(4):558-64. PubMed ID: 8176895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation.
    Soto C; Castaño EM; Frangione B; Inestrosa NC
    J Biol Chem; 1995 Feb; 270(7):3063-7. PubMed ID: 7852387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal lipid conjugation of amyloid β(1-40) leads to the formation of highly ordered N-terminally extended fibrils.
    Adler J; Scheidt HA; Lemmnitzer K; Krueger M; Huster D
    Phys Chem Chem Phys; 2017 Jan; 19(3):1839-1846. PubMed ID: 28000812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.
    Liepnieks JJ; Ghetti B; Farlow M; Roses AD; Benson MD
    Biochem Biophys Res Commun; 1993 Dec; 197(2):386-92. PubMed ID: 8267572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.